7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lightening skin tone is an ancient and well-documented practice, and remains common practice among many cultures. Whitening agents such as corticosteroids, tretinoin and hydroquinone are medically applied to effectively lighten the skin tone of hyperpigmented lesions. However, when these agents are used cosmetically, they are associated with a variety of side-effect. Alternative agents, such as arbutin and its derivatives kojic acid and nicotinamide have been subsequently developed for cosmetic purposes. Unfortunately, some cosmetics contain whitening agents that are banned for use in cosmetic products. This article provides an overview of the mode of action and potential side-effects of cosmetic legal and illegal whitening agents, and the pattern of use of these types of products. Finally, an EU analysis of the health problems due to the presence of illegal products on the market is summarized.

          Related collections

          Author and article information

          Journal
          J Eur Acad Dermatol Venereol
          Journal of the European Academy of Dermatology and Venereology : JEADV
          Wiley-Blackwell
          1468-3083
          0926-9959
          Jun 2016
          : 30
          : 6
          Affiliations
          [1 ] Division of Food, Medicines and Consumer Safety, Section Medicinal Products, Scientific Institute of Public Health (IPH), Brussels, Belgium.
          [2 ] Department of Toxicology, Dermato-Cosmetology and Pharmacognosy, Centre for Pharmaceutical Research (CePhar), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
          [3 ] Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
          Article
          10.1111/jdv.13595
          26953335
          00eb789e-f3d6-4dbf-9762-73ef03a61608
          History

          Comments

          Comment on this article